A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain

Journal of Proteomics

Volumn 74, Issue 4, 2011, Pages 547-557

  Sun, Yanwei ^a   Dierssen, Mara ^b   Toran, Nuria ^c   Pollak, Daniela D ^a   Chen, Wei Qiang ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Down syndrome; Fetal brain; Gel based proteomics; Mass spectrometry; Protein dysregulation

Indexed keywords

ALPHA INTERNEXIN; ALPHA TUBULIN; CREATINE KINASE; FATTY ACID BINDING PROTEIN; POTASSIUM CHLORIDE COTRANSPORTER; RNA BINDING PROTEIN; TROPOMODULIN;

ARTICLE; BRAIN; CONTROLLED STUDY; DNA TRANSPOSITION; DOWN SYNDROME; ELECTROPHYSIOLOGY; FEMALE; FETUS; FRONTAL CORTEX; FUNCTIONAL PROTEOMICS; GEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; ION TRANSPORT; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MALE; NERVE DEGENERATION; NEUROEPITHELIUM; NORMAL HUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEOMICS; RNA SPLICING; TWO DIMENSIONAL ELECTROPHORESIS;

BRAIN; BRAIN DISEASES, METABOLIC; CASE-CONTROL STUDIES; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETAL DISEASES; FETUS; GELS; GESTATIONAL AGE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; PREGNANCY; PROTEINS; PROTEOMICS;

EID: 79952242604     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.01.009     Document Type: Article

References (40)

1. Unterberger U., Lubec G., Dierssen M., Stoltenburg-Didinger G., Farreras J.C., Budka H. The cerebral cortex in fetal Down syndrome. J Neural Transm Suppl 2003, 159-163.
2. Engidawork E., Lubec G. Molecular changes in fetal Down syndrome brain. J Neurochem 2003, 84:895-904.
3. Shim K.S., Ferrando-Miguel R., Lubec G. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease. J Neural Transm Suppl 2003, 39-49.
4. Sanchez-Font M.F., Bosch-Comas A., Gonzalez-Duarte R., Marfany G. Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance. Nucleic Acids Res 2003, 31:2769-2777.
5. Cheon M.S., Bajo M., Kim S.H., Claudio J.O., Stewart A.K., Patterson D., et al. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II). Amino Acids 2003, 24:119-125.
6. Cheon M.S., Kim S.H., Ovod V., Kopitar Jerala N., Morgan J.I., Hatefi Y., et al. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III). Amino Acids 2003, 24:127-134.
7. Fountoulakis M., Gulesserian T., Lubec G. Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain. J Neural Transm Suppl 2003, 85-93.
8. Lubec G., Bajo M., Cheon M.S., Bajova H., Matherly L.H. Increased expression of human reduced folate carrier in fetal Down syndrome brain. J Neural Transm Suppl 2003, 95-103.
9. Ferrando-Miguel R., Cheon M.S., Lubec G. Aberrant chromosome 21 gene products: explaining the Down syndrome phenotype?. Neuroembryology 2004, 3:1-3.
10. Engidawork E., Gulesserian T., Fountoulakis M., Lubec G. Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience 2003, 122:145-154.
11. Gulesserian T., Engidawork E., Fountoulakis M., Lubec G. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40kDa protein in fetal Down syndrome. Cell Mol Biol Noisy grand 2003, 49:733-738.
12. Myung J.K., Gulesserian T., Fountoulakis M., Lubec G. Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain. Cell Mol Biol Noisy grand 2003, 49:739-746.
13. Shin J.H., Gulesserian T., Weitzdoerfer R., Fountoulakis M., Lubec G. Derangement of hypothetical proteins in fetal Down's syndrome brain. Neurochem Res 2004, 29:1307-1316.
14. Gulesserian T., Engidawork E., Fountoulakis M., Lubec G. Manifold decrease of sialic acid synthase in fetal Down syndrome brain. Amino Acids 2007, 32:141-144.
15. Rachidi M., Lopes C. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome. Am J Intellect Dev Disabil 2010, 115:83-112.
16. Oppermann M., Cols N., Nyman T., Helin J., Saarinen J., Byman I., et al. Identification of foetal brain proteins by two-dimensional gel electrophoresis and mass spectrometry comparison of samples from individuals with or without chromosome 21 trisomy. Eur J Biochem 2000, 267:4713-4719.
17. Weitzdorfer R., Hoger H., Burda G., Pollak A., Lubec G. Differences in hippocampal protein expression at 3days, 3weeks, and 3months following induction of perinatal asphyxia in the rat. J Proteome Res 2008, 7:1945-1952.
18. Zheng J., Patil S.S., Chen W.Q., An W., He J., Hoger H., et al. Hippocampal protein levels related to spatial memory are different in the Barnes maze and in the Multiple T-maze. J Proteome Res 2009, 8:4479-4486.
19. Kang S.U., Fuchs K., Sieghart W., Pollak A., Csaszar E., Lubec G. Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains. Nat Protoc 2009, 4:1093-1102.
20. Cox P.R., Fowler V., Xu B., Sweatt J.D., Paylor R., Zoghbi H.Y. Mice lacking Tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol Cell Neurosci 2003, 23:1-12.
21. Park M.H., Wolff E.C., Folk J.E. Is hypusine essential for eukaryotic cell proliferation?. Trends Biochem Sci 1993, 18:475-479.
22. Arai Y., Funatsu N., Numayama-Tsuruta K., Nomura T., Nakamura S., Osumi N. Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. J Neurosci 2005, 25:9752-9761.
23. Poirier K., Keays D.A., Francis F., Saillour Y., Bahi N., Manouvrier S., et al. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A). Hum Mutat 2007, 28:1055-1064.
24. Reissmann S., Hochleitner E., Wang H., Paschos A., Lottspeich F., Glass R.S., et al. Taming of a poison: biosynthesis of the NiFe-hydrogenase cyanide ligands. Science 2003, 299:1067-1070.
25. Liem R.K., Messing A. Dysfunctions of neuronal and glial intermediate filaments in disease. J Clin Invest 2009, 119:1814-1824.
26. Bauer J., Teufel U., Doege C., Hans-Juergen G., Beedgen B., Linderkamp O. Energy expenditure in neonates with Down syndrome. J Pediatr 2003, 143:264-266.
27. Kim S.H., Fountoulakis M., Dierssen M., Lubec G. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains. J Neural Transm Suppl 2001, 109-116.
28. Gumport R.I., Lehman I.R. Structure of the DNA ligase-adenylate intermediate: lysine (epsilon-amino)-linked adenosine monophosphoramidate. Proc Natl Acad Sci USA 1971, 68:2559-2563.
29. Lai M.C., Kuo H.W., Chang W.C., Tarn W.Y. A novel splicing regulator shares a nuclear import pathway with SR proteins. EMBO J 2003, 22:1359-1369.
30. Takao T., Yoshino K., Suzuki N., Shimonishi Y. Analysis of post-translational modifications of proteins by accurate mass measurement in fast atom bombardment mass spectrometry. Biomed Environ Mass Spectrom 1990, 19:705-712.
31. Le Rouzic P., Ivanov T.R., Stanley P.J., Baudoin F.M., Chan F., Pinteaux E., et al. KCC3 and KCC4 expression in rat adult forebrain. Brain Res 2006, 1110:39-45.
32. Babiloni C., Albertini G., Onorati P., Muratori C., Buffo P., Condoluci C., et al. Cortical sources of EEG rhythms are abnormal in down syndrome. Clin Neurophysiol 2010, 121:1205-1212.
33. Kieliszewski M.J., O'Neill M., Leykam J., Orlando R. Tandem mass spectrometry and structural elucidation of glycopeptides from a hydroxyproline-rich plant cell wall glycoprotein indicate that contiguous hydroxyproline residues are the major sites of hydroxyproline O-arabinosylation. J Biol Chem 1995, 270:2541-2549.
34. Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci 2008, 24:161-166.
35. Nagase T., Kikuno R., Ohara O. Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res 2001, 8:319-327.
36. Khazina E., Weichenrieder O. Non-LTR retrotransposons encode noncanonical RRM domains in their first open reading frame. Proc Natl Acad Sci USA 2009, 106:731-736.
37. de Parseval N., Heidmann T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res 2005, 110:318-332.
38. Lux A., Beil C., Majety M., Barron S., Gallione C.J., Kuhn H.M., et al. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1. J Biol Chem 2005, 280:8482-8493.
39. Deininger P.L., Batzer M.A. Mammalian retroelements. Genome Res 2002, 12:1455-1465.
40. Shin J.H., Krapfenbauer K., Lubec G. Mass-spectrometrical analysis of proteins encoded on chromosome 21 in human fetal brain. Amino Acids 2006, 31:435-447.